Filing Details

Accession Number:
0001209191-19-019753
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-15 17:17:25
Reporting Period:
2019-03-13
Accepted Time:
2019-03-15 17:17:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
917520 Integra Lifesciences Holdings Corp IART Surgical & Medical Instruments & Apparatus (3841) 510317849
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187576 E Richard Caruso 795 E Lancaster Avenue, Suite 200
Villanova PA 19085
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-03-13 9,250 $21.97 143,384 No 4 M Direct
Common Stock Disposition 2019-03-13 9,250 $56.06 134,134 No 4 S Direct
Common Stock Acquisiton 2019-03-13 20,878 $21.97 155,012 No 4 M Direct
Common Stock Disposition 2019-03-13 20,878 $56.06 134,134 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2019-03-13 9,250 $0.00 9,250 $21.97
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2019-03-13 20,878 $0.00 20,878 $21.97
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,878 2019-05-17 No 4 M Direct
0 2019-05-17 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 11,982,410 Indirect By Partnership
Common Stock 4,000 Indirect By Son
Footnotes
  1. 25% of the stock options vest every quarter from the grant date of 5/17/2011
  2. This option was previously reported as covering 4,431 shares at an exercise price of $50.78 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 4,625 shares of common stock at an exercise price of $43.93 per share.
  3. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.
  4. This option was previously reported as covering 10,000 shares at an exercise price of $50.78 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 10,439 shares of common stock at an exercise price of $43.93 per share.